Waters (WAT) Announces Earnings Results

Waters (NYSE:WAT) announced its quarterly earnings results on Tuesday. The medical instruments supplier reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.04, Bloomberg Earnings reports. The firm had revenue of $530.70 million for the quarter, compared to analysts’ expectations of $534.17 million. Waters had a net margin of 0.88% and a return on equity of 24.70%. Waters’s revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.46 earnings per share. Waters updated its FY18 guidance to $8.10-8.30 EPS.

WAT opened at $193.45 on Tuesday. The firm has a market capitalization of $16,403.71, a P/E ratio of 27.98, a P/E/G ratio of 2.44 and a beta of 0.93. The company has a debt-to-equity ratio of 0.85, a quick ratio of 6.60 and a current ratio of 7.04. Waters has a 12-month low of $160.52 and a 12-month high of $220.20.

How to Become a New Pot Stock Millionaire

In related news, SVP Terrence P. Kelly sold 1,312 shares of the company’s stock in a transaction on Friday, March 9th. The shares were sold at an average price of $212.52, for a total value of $278,826.24. Following the sale, the senior vice president now directly owns 5,130 shares of the company’s stock, valued at $1,090,227.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark T. Beaudouin sold 42,143 shares of the company’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total transaction of $9,153,881.03. Following the completion of the sale, the senior vice president now directly owns 20,749 shares in the company, valued at $4,506,890.29. The disclosure for this sale can be found here. Insiders sold 73,794 shares of company stock worth $16,057,538 over the last ninety days. 0.98% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of WAT. Xact Kapitalforvaltning AB increased its stake in Waters by 13.8% during the fourth quarter. Xact Kapitalforvaltning AB now owns 8,437 shares of the medical instruments supplier’s stock valued at $1,630,000 after purchasing an additional 1,023 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. increased its stake in Waters by 65.2% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 3,800 shares of the medical instruments supplier’s stock valued at $734,000 after purchasing an additional 1,500 shares during the last quarter. Banco de Sabadell S.A bought a new stake in Waters during the fourth quarter valued at $193,000. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp increased its stake in Waters by 72.3% during the fourth quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 44,100 shares of the medical instruments supplier’s stock valued at $8,520,000 after purchasing an additional 18,500 shares during the last quarter. Finally, MetLife Investment Advisors LLC bought a new stake in Waters during the fourth quarter valued at $4,754,000. 94.53% of the stock is currently owned by hedge funds and other institutional investors.

WAT has been the topic of a number of recent research reports. BTIG Research reaffirmed a “buy” rating on shares of Waters in a research report on Thursday, January 25th. Janney Montgomery Scott boosted their target price on shares of Waters from $200.00 to $230.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $217.00 target price on the stock in a research report on Tuesday, December 26th. ValuEngine raised shares of Waters from a “hold” rating to a “buy” rating in a research report on Monday, March 19th. Finally, Barclays boosted their target price on shares of Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 24th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Waters has an average rating of “Buy” and a consensus target price of $205.50.

ILLEGAL ACTIVITY WARNING: “Waters (WAT) Announces Earnings Results” was reported by Week Herald and is the property of of Week Herald. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://weekherald.com/2018/04/24/waters-wat-announces-earnings-results.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Earnings History for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply